Editorial
Adverse Drug Effects and Pegylation
Abstract
Adverse drug reactions (ADRs) are commonplace these days. With so many pharmaceuticals used to treat so many varied diseases in patients of varying types, it is no wonder that ADR case reports have become common. In this issue of the Southern Medical Journal Ji et al1 document a case of pleural effusion and interstitial pneumonitis after treatment with pegylated interferon for hepatitis C virus (HCV) infection. This case is interesting on two fronts. First, hepatitis C is a major health issue worldwide, with an estimated 170 million people infected.2 Second, various drugs may be beneficial in treating hepatitis C, but interferon remains a mainstay of therapy. Understanding and documenting potential adverse effects from a commonly used treatment modality is vital to anticipating potential ADRs and preventing their occurrence.3This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.